News
US-based Biotechnology Company #Moderna Announced That It Has Started Human Trials of an ... - Latest Tweet by IANS Tweets
The latest Tweet by IANS Tweets states, 'US-based biotechnology company #Moderna announced that it has started human trials of an #mRNA-based flu shot. The pharma giant said the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the company's quadrivalent seasonal influenza mRNA vaccine candidate.'
US-based biotechnology company #Moderna announced that it has started human trials of an #mRNA-based flu shot.
The pharma giant said the first participants have been dosed in the Phase 1/2 study of mRNA-1010, the company's quadrivalent seasonal influenza mRNA vaccine candidate. pic.twitter.com/trer80L9wE— IANS Tweets (@ians_india) July 7, 2021
(The above story first appeared on LatestLY on Jul 07, 2021 10:14 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
